Skip to main content
. 2005 Feb;139(2):348–354. doi: 10.1111/j.1365-2249.2004.02647.x

Table 1.

Patients’ characteristics and analysis of CD4 and CD8 T cell subsets.

dSSc (n = 11) lSSc (n = 11) RP (n = 10) Ctrl (n = 11)
Age (years)(mean ± SEM) 48 ± 4 54 ± 2 46 ± 3 52 ± 2
Sex ratio (female/male) 10/1  8/3  7/3  9/2
Duration of the disease (mean ± SEM; years)  7 ± 1·6  8 ± 1·3
Total lymphocyte counts (109/l) 42 ± 7 55 ± 9 44 ± 4 47 ± 6
CD4+ (% ± SEM) 48 ± 2 52 ± 2 38 ± 4 45 ± 2
CD8+ (% ± SEM) 19 ± 2* 24 ± 2 27 ± 3 29 ± 2
CD4+ HLA-DR+ (% ± SEM)  3 ± 1  3 ± 1  4 ± 1  3 ± 1
CD4+ CD25+ (% ± SEM)  2 ± 1  4 ± 1  5 ± 1  3 ± 1
CD8+ HLA-DR+ (% ± SEM)  4 ± 1  5 ± 1  5 ± 1  5 ± 1
CD8+ CD25+ (% ± SEM)  2 ± 2  1 ± 0·3  1 ± 1  0 ± 0·3

dSSc, diffuse systemic sclerosis; lSSc, limited systemic sclerosis; RP, primary Raynaud's phenomenon: Ctrl, controls (healthy volunteers).

*

P < 0·05 as compared to Ctrl (Mann–Whitney test).